BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32909370)

  • 1. Persistent HIV-controllers are more prone to spontaneously clear HCV: a retrospective cohort study.
    Dominguez-Molina B; Tarancon-Diez L; Milanés-Guisado Y; Genebat M; Resino S; Rodriguez C; Gonzalez-García J; Rallón N; Pernas M; Casado C; Lopez-Galíndez C; León A; Benito JM; García F; Del Romero J; Viciana P; Lopez-Cortes LF; Leal M; Ruiz-Mateos E;
    J Int AIDS Soc; 2020 Sep; 23(9):e25607. PubMed ID: 32909370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus replication in Caucasian HIV controllers.
    Ruiz-Mateos E; Machmach K; Romero-Sanchez MC; Ferrando-Martinez S; Viciana P; Del Val M; Muñoz-Fernandez MA; Genebat M; Leal M;
    J Viral Hepat; 2011 Jul; 18(7):e350-7. PubMed ID: 21692947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance-Supercontrollers.
    Dominguez-Molina B; Ferrando-Martinez S; Tarancon-Diez L; Hernandez-Quero J; Genebat M; Vidal F; Muñoz-Fernandez MA; Leal M; Koup R; Ruiz-Mateos E
    Front Immunol; 2018; 9():2897. PubMed ID: 30619267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection.
    Kim AY; Schulze zur Wiesch J; Kuntzen T; Timm J; Kaufmann DE; Duncan JE; Jones AM; Wurcel AG; Davis BT; Gandhi RT; Robbins GK; Allen TM; Chung RT; Lauer GM; Walker BD
    PLoS Med; 2006 Dec; 3(12):e492. PubMed ID: 17194190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers.
    Asher AK; Santos GM; Evans J; Dokubo EK; Lee TH; Martin JN; Deeks SG; Tobler LH; Busch M; Hunt PW; Page K
    AIDS; 2013 Nov; 27(17):2691-6. PubMed ID: 23939233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of spontaneous clearance of hepatitis C virus in a Danish human immunodeficiency virus type 1 cohort.
    Clausen LN; Weis N; Schønning K; Fenger M; Krarup H; Bukh J; Benfield T
    Scand J Infect Dis; 2011 Oct; 43(10):798-803. PubMed ID: 21728744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long-term non-progressors co-infected with hepatitis C virus.
    Alatrakchi N; Di Martino V; Thibault V; Autran B;
    AIDS; 2002 Mar; 16(5):713-7. PubMed ID: 11964527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study.
    López-Huertas MR; Palladino C; Garrido-Arquero M; Esteban-Cartelle B; Sánchez-Carrillo M; Martínez-Román P; Martín-Carbonero L; Ryan P; Domínguez-Domínguez L; Santos IL; Moral SF; Benito JM; Rallón N; Alcamí J; Resino S; Fernández-Rodríguez A; Coiras M; Briz V;
    Sci Rep; 2019 Apr; 9(1):5606. PubMed ID: 30944340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.
    Pernas M; Tarancón-Diez L; Rodríguez-Gallego E; Gómez J; Prado JG; Casado C; Dominguez-Molina B; Olivares I; Coiras M; León A; Rodriguez C; Benito JM; Rallón N; Plana M; Martinez-Madrid O; Dapena M; Iribarren JA; Del Romero J; García F; Alcamí J; Muñoz-Fernández M; Vidal F; Leal M; Lopez-Galindez C; Ruiz-Mateos E
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29212942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses.
    Lauer GM; Nguyen TN; Day CL; Robbins GK; Flynn T; McGowan K; Rosenberg ES; Lucas M; Klenerman P; Chung RT; Walker BD
    J Virol; 2002 Mar; 76(6):2817-26. PubMed ID: 11861849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High CD8 T cell percentage and HCV replication control are common features in HIV-1 controllers and HTLV-2-co-infected patients with a history of injection drug use.
    Ruiz-Mateos E; Ruiz-León MJ; Tarancón-Díez L; Gutiérrez C; Dronda F; Domínguez-Molina B; Pérez-Elías MJ; Moreno A; Leal M; Moreno S; Vallejo A
    Virus Res; 2019 Apr; 264():40-44. PubMed ID: 30776394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission and evolution of hepatitis C virus in HCV seroconverters in HIV infected subjects.
    Shen C; Gupta P; Xu X; Sanyal A; Rinaldo C; Seaberg E; Margolick JB; Martinez-Maza O; Chen Y
    Virology; 2014 Jan; 449():339-49. PubMed ID: 24418568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
    Shores NJ; Maida I; Soriano V; Núnez M
    J Hepatol; 2008 Sep; 49(3):323-8. PubMed ID: 18486266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.
    Desai SN; Dodge JL; Landay AL; Glesby MJ; Latham PS; Villacres MC; French AL; Gange SJ; Greenblatt RM; Peters MG
    Medicine (Baltimore); 2016 Aug; 95(33):e4483. PubMed ID: 27537569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV reinfections after viral clearance among HIV-positive patients with recent HCV infection in Taiwan.
    Huang MH; Chang SY; Liu CH; Cheng A; Su LH; Liu WC; Su YC; Sun HY; Hung CC; Chang SC
    Liver Int; 2019 Oct; 39(10):1860-1867. PubMed ID: 31343813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression.
    Morsica G; Bagaglio S; Ghezzi S; Lodrini C; Vicenzi E; Santagostino E; Gringeri A; Cusini M; Carminati G; Bianchi G; Galli L; Lazzarin A; Poli G
    J Clin Virol; 2007 Jun; 39(2):82-6. PubMed ID: 17434339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
    Kerzerho J; McIlvaine EJ; Anthony P; Mack WJ; Wang CH; Frederick T; Operskalski E; Chen Z; Al-Harthi L; Landay A; Young MA; Tien PC; Augenbraun M; Strickler HD; Akbari O; Golub ET; Sharp GB; Kovacs A
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):172-80. PubMed ID: 26761519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus.
    Schnuriger A; Dominguez S; Guiguet M; Harfouch S; Samri A; Ouazene Z; Slama L; Simon A; Valantin MA; Thibault V; Autran B;
    AIDS; 2009 Oct; 23(16):2079-89. PubMed ID: 19710595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.